1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
